Therapeutic agent for nervous system disease
US12029751B2 · kind B2 · utility
0Cited by
3References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 4, 2023 |
| Grant date | Jul 9, 2024 |
| Priority date | — |
| Expiry date | May 4, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An object is to provide a drug which is useful in treating a nervous system disease. A drug containing vitamin B12 as an active ingredient according to the present invention has an M2 macrophage/microglia induction promoting effect, an M1 macrophage/microglia induction inhibiting effect, a nerve regeneration promoting effect, and the like and is very useful as a therapeutic agent for a nervous system disease, and particularly useful as a therapeutic agent for a central nervous system disease such as cerebral infarction, dementia, or spinal cord injury.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.